RSS

biopharmaceutical

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. more

News

A strategic partnership has been announced between biopharmaceutical contract services company, KBI, and provider of formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics, ReForm more

News

Clinical-stage biopharmaceutical company, Autolus, and provider of products and services for biomedical research and cellular therapy, Miltenyi Biotec, have signed a strategic long-term supply agreement. more

News

Rentschler Biopharma and Leukocare have reported the success of the first year of their strategic alliance, incorporating formulation development in each step of the biopharmaceutical development and manufacturing process. more

News

Debiopharm Group, international biopharmaceutical group, has continued its efforts in the fight against antibiotic resistance by investing in antibiotic development through acquiring a minority stake in ABAC Therapeutics. more

News

Specialty biopharmaceutical group, Ferring Pharmaceuticals, has announced its 30 million CHF investment in its new biotech centre in Switzerland. more

News

Abeona Therapeutics, a clinical-stage biopharmaceutical company, has received regenerative medicine advanced therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its for its gene therapy in epidermolysis bullosa in EB-101. more

News

Sanofi is to acquire all outstanding ordinary shares of a biopharmaceutical company that is currently focused on the discovery and development of Nanobodies, Ablynx. more

News

A definitive acquisition agreement has been formed between Sanofi and biopharmaceutical company, Bioverativ, which will see Sanofi acquire all the outstanding shares of Bioverativ for an equity value of approximately $11.6 billion. more

News

Monoclonal antibodies (MAb) solutions are a major class of biopharmaceuticals with various applications. They are important for treating diseases such as cancer, inflammation, allergies, infectious diseases and cardiovascular diseases. more

Motif Bio has received an award from the Cystic Fibrosis Foundation, which will fund important in vitro testing to advance the development of iclaprim for the treatment of lung infections in patients with cystic fibrosis more

News

The FDA has accepted an IND application by biopharmaceutical company, InflaRx, which will enable the company to initiate a Phase IIb study evaluating the efficacy and safety of IFX-1 in patients with moderate or severe Hidradenitis Suppurativa. more

News

Full-service contract manufacturer of biopharmaceutical proteins, Wacker Biotech, has obtained US Food and Drug Administration (FDA) approval to manufacture reteplase — the active ingredient in the drug Retavase. more

News

Takeda Pharmaceutical Company has announced its intention to acquire the advanced biopharmaceutical company, TiGenix. more

News

Clinical-stage biopharmaceutical company, Autolus, has announced the publication of pre-clinical data of a novel, dual-targeted, proliferating-inducing ligand (APRIL) chimeric antigen receptor (CAR) for the treatment of multiple myeloma. more

News

Dr Hani El-Sabbahy, a biopharmaceutical application engineering specialist at science-based technology company 3M, outlines some of the challenges associated with continuous multicolumn protein A chromatography. more

Opinion

Clinical-stage biopharmaceutical company, Autolus, has presented data for its pan-checkpoint blocking technology at the American Society of Hematology (ASH) annual meeting in Atlanta. more

News

SGS, a bio/pharmaceutical analytical and bioanalytical contract solutions provider, has launched new large molecule bioanalytical services at its laboratory in Wavre, Belgium. more

News

WIRB Copernicus Group (WCG) has acquired a provider of integrated end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry, Vigilare International. more

News

GE Healthcare has announced the completion of its acquisition of a bioprocessing start-up, Puridify — which is developing a nanofiber-based platform purification technology for biopharmaceutical production. more

News